Icecure Medical Ltd Revenue Growth Rates (ICCM), Current and Historic Growth - CSIMarket
CSIMarket
 


Icecure Medical Ltd  (NASDAQ: ICCM)
 

ICCM's Revenue Growth by Quarter and Year

Icecure Medical Ltd's Revenue results by quarter and year




ICCM Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 3.38
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 3.38

ICCMs Annual Revenue
Icecure Medical Ltd's Revenue in the fiscal year 2025 $ 3.38 millions
Icecure Medical Ltd's Revenue in the fiscal year 2024 $ 3.29 millions
Icecure Medical Ltd's Revenue in the fiscal year 2023 $ 3.23 millions
Icecure Medical Ltd's Revenue in the fiscal year 2022 $ 3.09 millions
Icecure Medical Ltd's Revenue in the fiscal year 2021 $ 4.14 millions




ICCM Revenue fourth quarter 2025 Y/Y Growth Comment
Icecure Medical Ltd achieved in the fourth quarter 2025, above Company average Revenue rise of 46.91% year on year, to $ 3.38 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue growth. While Icecure Medical Ltd' s Revenue jump of 46.91% ranks overall at the positon no. 591 in the fourth quarter 2025.




ICCM Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December 46.91 % -25.57 % -25.36 % -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   46.91 % -25.57 % -25.36 % -

Financial Statements
Icecure Medical Ltd's fourth quarter 2025 Revenue $ 3.38 millions ICCM's Income Statement
Icecure Medical Ltd's fourth quarter 2024 Revenue $ 2.30 millions Quarterly ICCM's Income Statement


ICCM Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   46.91 % -25.57 % -25.36 % -




Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #139
Overall #591

Revenue Y/Y Growth Statistics
High Average Low
-25.45 % -25.45 % -25.45 %
(Dec 31 2023)   (Dec 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #139
Overall #591
Revenue Y/Y Growth Statistics
High Average Low
-25.45 % -25.45 % -25.45 %
(Dec 31 2023)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Icecure Medical Ltd's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ICCM's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ICCM's IV. Quarter Q/Q Revenue Comment


Icecure Medical Ltd's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
Cumulative Revenue 12 Months Ending $ 3.38 $ 3.29 $ 3.23 $ 3.09 $ 0.00
Y / Y Revenue Growth (TTM) 2.67 % 1.92 % 4.67 % -25.45 % -
Year on Year Revenue Growth Overall Ranking # 2704 # 2634 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 2.67 % 1.92 % 4.67 % -25.45 % -
Seq. Revenue Growth (TTM) Overall Ranking # 2704 # 2835 # 0 # 0 # 0


Cumulative Revenue growth Comment
Icecure Medical Ltd saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 2.67% year on year, to $ 3 millions if the fiscal year would have ended in Dec 31 2025.
Icecure Medical Ltd's trailing twelve months Revenue growth was higher than company's average -25.45% and higher than 1.92% growth in Dec 31 2024.
The momentum is even more impressive from twelve months ended Dec 31 2024 exhibited at 2.67 % increase from $3.29 millions in the period from Dec 31 2024 to .

In the Healthcare sector 349 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2634 to 2704.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 350
Overall # 2704

Revenue TTM Y/Y Growth Statistics
High Average Low
-25.45 %
-25.45 %
-25.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 350
S&P 500 # 2704
Cumulative Revenue growth Comment
Icecure Medical Ltd saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 2.67% year on year, to $ 3 millions if the fiscal year would have ended in Dec 31 2025.
Icecure Medical Ltd's trailing twelve months Revenue growth was higher than company's average -25.45% and higher than 1.92% growth in Dec 31 2024.
The momentum is even more impressive from twelve months ended Dec 31 2024 exhibited at 2.67 % increase from $3.29 millions in the period from Dec 31 2024 to .

In the Healthcare sector 349 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2634 to 2704.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 350
Overall # 2704

Revenue TTM Y/Y Growth Statistics
High Average Low
-25.45 %
-25.45 %
-25.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 350
S&P 500 # 2704




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICCM's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Arcutis Biotherapeutics Inc 81.48%$ 81.478 millions
Aclarion Inc 80.59%$ 80.590 millions
X4 Pharmaceuticals Inc79.08%$ 79.079 millions
Intellia Therapeutics Inc 78.79%$ 78.787 millions
Envoy Medical Inc 78.57%$ 78.571 millions
Organogenesis Holdings Inc 78.13%$ 78.126 millions
Tg Therapeutics Inc 78.00%$ 78.004 millions
Eton Pharmaceuticals Inc 77.14%$ 77.140 millions
Trisalus Life Sciences Inc 76.95%$ 76.954 millions
Co diagnostics Inc 76.74%$ 76.743 millions
Ss Innovations International Inc76.54%$ 76.537 millions
Cellectis S a 75.76%$ 75.760 millions
Fennec Pharmaceuticals Inc 73.84%$ 73.842 millions
Travere Therapeutics Inc 73.41%$ 73.410 millions
Inspiremd Inc 69.30%$ 69.299 millions
Viridian Therapeutics Inc 68.06%$ 68.056 millions
Sol gel Technologies Ltd 68.04%$ 68.036 millions
Novavax inc 66.61%$ 66.615 millions
Beyond Air Inc 65.61%$ 65.605 millions
Axsome Therapeutics Inc 65.03%$ 65.030 millions
Kiniksa Pharmaceuticals International Plc64.95%$ 64.953 millions
Precision Optics Corporation Inc 62.76%$ 62.757 millions
Organigram Global Inc 62.15%$ 62.151 millions
Cardiff Oncology Inc 62.00%$ 62.000 millions
Beta Bionics Inc 61.17%$ 61.174 millions
Catheter Precision Inc 59.73%$ 59.732 millions
Euda Health Holdings Limited59.29%$ 59.292 millions
Xoma Royalty Corporation57.87%$ 57.872 millions
Immuron Limited55.99%$ 55.993 millions
Ideaya Biosciences Inc 55.37%$ 55.371 millions


About Icecure Medical Ltd Revenue Growth Rates (ICCM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Icecure Medical Ltd (CIK 1584371).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-028684
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Icecure Medical Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.